Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
B Cell
50%
Patient
45%
Neoplasm
33%
Combination Therapy
30%
Gene
29%
Cyclic AMP
25%
Phosphodiesterase
25%
Therapeutic Procedure
22%
Cancer
20%
Chronic Myelogenous Leukemia
20%
B Lymphocyte Receptor
19%
microRNA
18%
Angiogenesis
16%
Programmed Cell Death
16%
Myeloproliferative Disorder
16%
Cell Line
15%
Imatinib
15%
Toxin
14%
Phosphodiesterase IV Inhibitor
14%
Lymphoma
14%
Development
13%
Leukemia
13%
Analysis
13%
Diseases
12%
Aggressive Lymphoma
12%
Nuclear Factor
12%
Alternative Complement Pathway C3 C5 Convertase
12%
B-Cell Lymphoma
12%
Acute Lymphoblastic Leukemia
11%
Phosphotransferase
11%
Non-Hodgkin Lymphoma
11%
Eosinophilia
10%
Receptor
10%
Family
10%
Phosphodiesterase IV
10%
Cells
9%
Pathogenesis
9%
Blast Cell Crisis
9%
In Vitro
9%
Microenvironment
9%
Poly ADP Ribose Polymerase
9%
Secretion (Process)
9%
Hematologic Malignancy
9%
Survival
8%
Tumor Suppressor Gene
8%
Programmed Death-Ligand 1
8%
Protein P53
7%
Chemotherapy
7%
Diffuse Large B-Cell Lymphoma Cell Line
7%
Biochemistry, Genetics and Molecular Biology
Nested Gene
77%
B Cell
69%
Mutation
47%
Myeloid
38%
MicroRNA
37%
Protein
33%
Sample
24%
Southern Blotting
18%
Development
15%
Transcription
15%
Germline
15%
Phosphodiesterase
15%
Imatinib
15%
P53
14%
DNA
14%
Mutant
13%
Genetics
13%
RNA
13%
Lysozyme
13%
Protein Tyrosine Phosphatase
13%
Wild Type
13%
Fluorescence in Situ Hybridization
12%
IDH2
12%
Exon
12%
Cyclic Adenosine Monophosphate
11%
P16
11%
C-Terminus
11%
Degradation
11%
Protein P53
10%
Aptitude
10%
Demethylase
10%
Ubiquitination
10%
Kinase
9%
Phenotype
9%
Probe
9%
Chromosome Band
9%
Epitranscriptome
9%
Epigenome
9%
Polymerase Chain Reaction
9%
Neural Crest
9%
Mouse
9%
N-Terminus
8%
Association
7%
FHIT
7%
Internalization
7%
Mammalian Target of Rapamycin
7%
Insulin Sensitivity
7%
Poly ADP Ribose Polymerase
7%
Insulin Resistance
7%
Yeast Artificial Chromosome
7%